The board of Cryo-Cell International, Inc. (NYSEAM:CCEL) announced the Spin-Off of Celle Corp. to its shareholders on March 25, 2024. The board of Directors of Cryo-Cell International has authorized the spin-off of its newly formed subsidiary, Celle Corp., to the Cryo-Cell shareholders currently anticipated to be in the form of a stock dividend to the Cryo-Cell shareholders and to occur in Cryo-Cell?s 2nd or 3rd fiscal quarters.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.14 USD | +0.77% | +0.11% | +58.96% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.96% | 74.07M | |
+16.49% | 82.59B | |
-29.52% | 69.86B | |
0.00% | 26.5B | |
-13.29% | 16.61B | |
+2.28% | 17.29B | |
+1.57% | 15.56B | |
+71.63% | 13.2B | |
+1.53% | 12.75B | |
+70.68% | 12.6B |
- Stock Market
- Equities
- CCEL Stock
- News Cryo-Cell International, Inc.
- Cryo-Cell International, Inc. agreed to Spin-Off Celle Corp.